Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
FDA Briefing Information for the July 22, 2013 Meeting of the Arthritis Advisory Committee (PDF – 238KB)
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Industry Briefing Information for the July 22, 2013 Meeting of the Arthritis Advisory Committee (PDF – 54KB)